Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Clinical Trial Investigating the Long-term Safety of Buntanetap in Treating Participants With Alzheimer's Disease

NCT07757204 is registered in ClinicalTrials.gov with Annovis Bio Inc. as lead sponsor.

NCT NCT07757204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07757204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Clinical Trial Investigating the Long-term Safety of Buntanetap in Treating Participants With Alzheimer's Disease
Lead sponsor
Annovis Bio Inc.
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
September 21, 2026
Completion date
May 31, 2030
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's dementia (ad)